Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
R. Leclercq  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Quinolone resistance among Shigella spp
Hydatid disease Clinical Microbiology and Infection
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
Potential risk factors for infection with Candida spp
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Structure of grepafloxacin relative to activity and safety profile
D.E. Low  Clinical Microbiology and Infection 
The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin  Inger Adamsson, Charlotta Edlund,
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
Carl Erik Nord, Ann Lidbeck, Kerstin Orrhage, Svante Sjöstedt 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
C. S. Higgins, S. M. Murtough, E. Williamson, S. J. Hiom, D. J
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Laboratory diagnosis of Clostridium difficile disease
J. Garau  Clinical Microbiology and Infection 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
C. Oprica, C.E. Nord  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Definition of the Clinical Antibacterial Spectrum of Activity
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
An after-hours clinical liaison blood culture service—is it worth it?
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
Brita Bruun, Henrik Westh, Jørgen Stenderup 
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece  J. Papaparaskevas, J. Stefanou, A. Vatopoulos,
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study  R. Goering, C.-E. Nord, R.
Modification of prescribers’ behavior: the Icelandic approach
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Fernando Baquero, John F
The future of diagnostic bacteriology
Presentation transcript:

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian Phillips  Clinical Microbiology and Infection  Volume 5, Issue 7, Pages 404-416 (July 1999) DOI: 10.1111/j.1469-0691.1999.tb00164.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Correlation of penicillin and piperacillin MICs for 813 isolates of non-Bacteroides fragilis anaerobic Gram-negative bacilli (NCCLS breakpoints: penicillin 0.5 mg/L, piperacillin 32 mg/L). Clinical Microbiology and Infection 1999 5, 404-416DOI: (10.1111/j.1469-0691.1999.tb00164.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Distribution of MICs of clindamycin, roxithromycin and HMR 3647 for 69 Porphyromonas spp. from Scandinavia (A), UK (B), central Europe (C) and southern/eastern Europe (D). See Table 5 for countries included in groups. Clinical Microbiology and Infection 1999 5, 404-416DOI: (10.1111/j.1469-0691.1999.tb00164.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.